Does Parathyroid Hormone Affect Erythropoietin Therapy in Dialysis Patients?

Abstract

CAPD patients showed a reduced requirement for rHuEPO and better control of anemia compared with HD patients. ERI was also lower in CAPD than in HD patients. Hyperparathyroidism is a parameter predictive of rHuEPO hyporesponsiveness in dialysis patients.